U.S. Physical Therapy, Inc. (NYSE:USPH) Expected to Post Quarterly Sales of $124.91 Million

Equities research analysts expect U.S. Physical Therapy, Inc. (NYSE:USPH) to announce sales of $124.91 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings, with estimates ranging from $123.61 million to $126.13 million. U.S. Physical Therapy reported sales of $115.10 million during the same quarter last year, which indicates a positive year over year growth rate of 8.5%. The firm is expected to report its next quarterly earnings results on Thursday, August 1st.

According to Zacks, analysts expect that U.S. Physical Therapy will report full-year sales of $491.74 million for the current financial year, with estimates ranging from $485.46 million to $495.77 million. For the next year, analysts expect that the business will post sales of $527.69 million, with estimates ranging from $505.79 million to $539.28 million. Zacks’ sales calculations are a mean average based on a survey of research analysts that follow U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.04. U.S. Physical Therapy had a return on equity of 19.09% and a net margin of 5.34%. The company had revenue of $116.23 million for the quarter, compared to analysts’ expectations of $114.12 million. U.S. Physical Therapy’s quarterly revenue was up 7.3% on a year-over-year basis.

A number of research analysts recently commented on USPH shares. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 price target on the stock in a report on Friday, April 26th. TheStreet raised U.S. Physical Therapy from a “c+” rating to a “b” rating in a report on Friday, March 8th. William Blair started coverage on U.S. Physical Therapy in a report on Thursday, March 7th. They issued an “outperform” rating and a $106.61 price target on the stock. Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, May 3rd. Finally, ValuEngine cut U.S. Physical Therapy from a “strong-buy” rating to a “buy” rating in a report on Wednesday, March 6th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $111.40.

NYSE USPH opened at $118.64 on Thursday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.18 and a current ratio of 1.18. U.S. Physical Therapy has a 12 month low of $95.50 and a 12 month high of $129.65. The company has a market capitalization of $1.51 billion, a P/E ratio of 44.77, a price-to-earnings-growth ratio of 3.60 and a beta of 1.11.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Friday, May 17th will be issued a dividend of $0.27 per share. The ex-dividend date is Thursday, May 16th. This represents a $1.08 annualized dividend and a dividend yield of 0.91%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 40.75%.

In other news, Director Kathleen A. Gilmartin acquired 500 shares of the firm’s stock in a transaction dated Friday, March 29th. The shares were acquired at an average cost of $105.17 per share, with a total value of $52,585.00. Following the acquisition, the director now directly owns 2,500 shares of the company’s stock, valued at $262,925. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Christopher J. Reading sold 19,860 shares of the company’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $119.36, for a total value of $2,370,489.60. The disclosure for this sale can be found here. Insiders have sold a total of 34,939 shares of company stock worth $4,068,338 over the last ninety days. Insiders own 2.50% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. increased its position in shares of U.S. Physical Therapy by 3.9% during the 1st quarter. BlackRock Inc. now owns 2,179,412 shares of the company’s stock valued at $228,903,000 after purchasing an additional 82,496 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its position in shares of U.S. Physical Therapy by 0.6% during the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,400,252 shares of the company’s stock valued at $147,068,000 after purchasing an additional 8,471 shares during the last quarter. Neuberger Berman Group LLC increased its position in shares of U.S. Physical Therapy by 4.6% during the 1st quarter. Neuberger Berman Group LLC now owns 902,762 shares of the company’s stock valued at $94,817,000 after purchasing an additional 39,329 shares during the last quarter. Northern Trust Corp increased its position in shares of U.S. Physical Therapy by 0.8% during the 1st quarter. Northern Trust Corp now owns 217,392 shares of the company’s stock valued at $22,833,000 after purchasing an additional 1,796 shares during the last quarter. Finally, Copeland Capital Management LLC increased its position in shares of U.S. Physical Therapy by 6.7% during the 1st quarter. Copeland Capital Management LLC now owns 174,084 shares of the company’s stock valued at $18,284,000 after purchasing an additional 10,902 shares during the last quarter. 99.58% of the stock is currently owned by institutional investors and hedge funds.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Story: Does the discount rate affect the economy?

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.